GQ1001 ADC Freeze-Drying Process for Stability and Reconstitution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing freeze-drying processes for antibody-drug conjugates (ADCs) face challenges in achieving uniform product quality, stability, and efficiency, particularly in maintaining protein integrity and biological activity, due to factors like cooling rates, vacuum pressures, and drying times.
Innovation Solution
A tailored freeze-drying process for ADCs, specifically GQ1001, involving controlled cooling rates, optimized vacuum pressures, and temperature gradients during pre-freezing, primary, and secondary drying stages, using a formulation comprising GQ1001, sodium succinate, sucrose, and polysorbate 20, to ensure uniformity and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If a fast cooling rate is used during pre-freezing, then the freeze-drying time is reduced, but the ADC product may suffer from protein denaturation and cell damage
Solution Approach 1:
The patent applies dynamic control of the cooling rate during pre-freezing, adjusting it from faster initial cooling to slower final cooling. This dynamic approach allows rapid ice crystal formation early in the process to reduce overall drying time, while slowing down near the end to prevent protein denaturation and maintain ADC integrity, thus resolving the contradiction between productivity and reliability.
2Stability of the object's composition
If a low vacuum pressure is used during drying, then ice sublimation is promoted, but heat transfer becomes inefficient and sublimation rate decreases
Solution Approach 1:
The patent employs parameter changes by dynamically adjusting vacuum pressure during the drying process. The pressure is optimized to maintain efficient sublimation while ensuring adequate heat transfer to the product. This involves changing pressure parameters over time to balance sublimation promotion with heat transfer efficiency, resolving the contradiction between sublimation efficiency and energy use.
3Reliability
If extended drying time is used, then moisture content is reduced to below 2%, but production efficiency decreases
Solution Approach 1:
The patent applies continuous useful action by optimizing the drying process to achieve moisture content below 2% through efficient parameter control rather than extended time. The continuous monitoring and adjustment of temperature, pressure, and heating rates ensures that drying is completed as quickly as possible while still achieving the target moisture level, thus maintaining both product stability and production efficiency.
4Productivity
If high heating rate is used during primary drying, then drying speed increases, but product temperature may exceed safe limits causing degradation
Solution Approach 1:
The patent implements feedback control by continuously monitoring product temperature during primary drying and adjusting the heating rate accordingly. When temperature approaches safe limits, the heating rate is automatically reduced to prevent degradation. This feedback mechanism allows high drying speeds to be maintained when conditions permit, while ensuring temperature control when needed, resolving the contradiction between productivity and temperature control.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process results in ADCs with stable physical and chemical properties, low moisture content, rapid reconstitution, and maintained biological activity, with no significant changes in protein concentration or purity over extended storage periods.
Implementation Method 1
lowering the temperature with a cooling rate of about 0.36° C./min or more
Implementation Method 2
raising the temperature and drying under the pressure of about 30 Pa or less
Implementation Method 3
raising the temperature and drying under the pressure of about 30 Pa or less
Implementation Method 4
raising the temperature to about 20-40° C.
Data Source
AI summary
Provided is a freeze-drying process for an antibody drug conjugate, wherein the ADC is GQ1001. Due to the use of the present freeze-drying process parameters, especially the suitable pre-freezing cooling rate and a suitable drying vacuum, the product obtained by the process has many advantages in physical and chemical properties.